Kimberly-Clark
Kimberly-Clark's revenue fell 2.1% to $16.4 billion in fiscal 2025. Its operating margin was 14.3%, down from 16.1% a year earlier. Free cash flow was $1.6 billion, down 34.8%. It paid out $1.8 billion in dividends and buybacks, 110% of free cash flow. The diluted share count fell 1.1%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
What Kimberly-Clark does
Kimberly-Clark makes and sells everyday paper and personal care products, including Huggies diapers, Kleenex tissues, Scott and Cottonelle bathroom tissue, Kotex and Poise pads, and Depend underwear for adults. It sells in more than 175 countries and territories. It groups its products into five categories: baby and child care, adult care, feminine care, family care and professional.
Household products go to supermarkets, mass merchandisers, drugstores, warehouse clubs and online stores. Products for professional use go through distributors and directly to businesses such as hotels, factories and food service operations. Its largest customer is Walmart. The company reports two segments by region: North America and International Personal Care. It says it has several major competitors, some larger and more diversified than itself.
Two deals are pending. Kimberly-Clark plans to sell a majority of its international family care and professional business to Suzano, a Brazilian company, forming a joint venture: Suzano will buy a 51% stake for about $1.7 billion and Kimberly-Clark will keep the rest. It has also agreed to buy Kenvue, a consumer health company, for stock and cash.
Its biggest risks, as it describes them
- Higher prices for raw materials, energy and shipping that it cannot pass on to customers.
- Intense competition, and failing to keep up with how consumers shop or to market its products well.
- Growing reliance on a few big retailers and on new online sales channels.
- The pending Kenvue deal may not close, or may not bring the benefits expected.
- Disruption to its supply chain, factories or distribution.
Charts show fiscal years, from the 10-K filings.
Revenue and margins
Net income and earnings per share
From fiscal 2016 to 2025, earnings per share grew 0.1% a year and net income fell 0.8% a year, as buybacks cut the share count by 8%.
Returns on capital
Cash flow
Payouts and share count
Valuation
Two ways to value Kimberly-Clark yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.
Discounted cash flow (DCF)
A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from Kimberly-Clark's 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.
Value per share on three example scenarios, from Kimberly-Clark's fiscal 2025 free cash flow of $1.6B, net cash of −$6.5B at December 31, 2025 and 333 million diluted shares, from its filings. The scenarios are fitted to Kimberly-Clark: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, -6.6% a year, kept between 0% and 20%; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 8%: 7% for a stable business (Household Products), plus 1 point for unsteady results (revenue fell in two of the last five years); the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $109.63
- Value on these assumptions, against the last close
- —
- Cash flows in years 1 to 10, valued today
- —
- Everything after year 10, valued today
- —
- Plus net cash
- —
- Share of value from after year 10
How the value changes with two assumptions
Price-to-earnings (P/E) method
Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.
Value per share on three example scenarios, from Kimberly-Clark's earnings per share of $5.88 (over the last four quarters). Each grows earnings for a year at the cash flow scenarios' rates and applies a multiple to next year's earnings: 24.6×, the middle of Kimberly-Clark's own P/E today, its peers' median and its sector's median (the Consumer Staples median) for the base scenario, 20% less and more for the cautious and optimistic ones. The price is brought back a year at 9%, 8% and 7%. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $109.63
- Value at this multiple, against the last close
- —
- Kimberly-Clark's P/E at the last close
- 18.6×
| Company | Last close | Earnings per share | P/E today |
|---|---|---|---|
| Colgate-PalmoliveCL | $93.10 | $2.53 | 36.8× |
| Church & DwightCHD | $105.38 | $3.12 | 33.8× |
| Kimberly-ClarkKMB | $109.63 | $5.88 | 18.6× |
| Central Garden & PetCENT | $45.28 | $2.70 | 16.8× |
| Reynolds Consumer ProductsREYN | $23.01 | $1.57 | 14.7× |
Balance sheet
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 0.3 | 0.4 | 1.1 | 1.0 | 0.7 |
| Debt incl. finance leases | 8.6 | 8.4 | 8.0 | 7.4 | 7.2 |
| Net debt (negative means net cash) | 8.3 | 8.0 | 6.9 | 6.4 | 6.5 |
| Net debt to EBITDA | 2.5x | 2.3x | 2.6x | 1.8x | 2.0x |
| Debt to equity | — | — | 8.7x | 8.8x | 4.8x |
| Interest coverage | 10.0x | 9.5x | 6.6x | 10.0x | 9.2x |
| Current ratio | 0.8x | 0.8x | 0.8x | 0.8x | 0.8x |
| Quick ratio | 0.5x | 0.5x | 0.5x | 0.6x | 0.5x |
Insider trades
Over the 12 months between October 27, 2025 and October 26, 2026, 1 insider bought $1.0 million of Kimberly-Clark shares on the open market, and 2 insiders sold $1.0 million.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| May 6, 2026 | Andrew ScribnerController, VP & Fp&a | Sold | 4,095 | $98.00 | $401,310 | Form 4 |
| May 4, 2026 | Katy ChenPresident, Int'l Personal Care | Sold | 1,596 | $95.34 | $152,163 | Form 4 |
| Apr 30, 2026 | Katy ChenPresident, Int'l Personal Care | Sold | 1,405 | $96.96 | $136,229 | Form 4 |
| Feb 9, 2026 | Todd MaclinDirector | Bought | 10,000 | $104.15 | $1.0 million | Form 4 |
| Feb 5, 2026 | Andrew ScribnerController, VP & Fp&a | Sold | 3,049 | $104.29 | $317,980 | Form 4 |
Piotroski F-score
The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Fail | Pass | Fail |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Pass | Pass | Pass |
| Current ratio rose | Pass | Fail | Fail |
| Share count didn't rise | Fail | Pass | Pass |
| Gross margin rose | Pass | Pass | Fail |
| Revenue rose relative to assets | Fail | Pass | Pass |
| F-score | 6 of 9 | 8 of 9 | 6 of 9 |
| Accruals ratio | −10.1% | −4.1% | −4.5% |
Compare
Put Kimberly-Clark side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Kimberly-Clark | FY25 | −2.1% | 14.3% | 10.0% | 21.5% | 2.0x | 6 | |
| Colgate-Palmolive | FY25 | 1.4% | 16.2% | 17.8% | 37.3% | 1.6x | 5 | Compare |
| Church & Dwight | FY25 | 1.6% | 17.4% | 17.6% | 14.6% | 1.4x | 6 | Compare |
| Reynolds Consumer Products | FY25 | 0.7% | — | 8.5% | 9.9% | 2.4x | 5 | Compare |
| Central Garden & Pet | FY25 | −2.2% | 8.0% | 9.3% | 9.7% | 0.9x | 8 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 18.3 | 18.3 | 18.5 | 18.4 | 19.1 | 19.4 | 20.2 | 17.1 | 16.8 | 16.4 |
| Revenue growth | −1.6% | 0.3% | 0.8% | −0.2% | 3.7% | 1.6% | 3.8% | −15.0% | −2.0% | −2.1% |
| Gross profit | 6.7 | 6.6 | 5.6 | 6.0 | 6.8 | 6.0 | 6.2 | 6.3 | 6.3 | 5.9 |
| Research and development | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
| Operating income | 3.4 | 3.4 | 2.2 | 3.0 | 3.2 | 2.6 | 2.7 | 1.9 | 2.7 | 2.4 |
| Net income | 2.2 | 2.3 | 1.4 | 2.2 | 2.4 | 1.8 | 1.9 | 1.8 | 2.5 | 2.0 |
| Diluted EPS (US$) | 5.99 | 6.40 | 4.03 | 6.24 | 6.87 | 5.35 | 5.72 | 5.21 | 7.55 | 6.07 |
| Diluted shares (millions) | 362 | 356 | 350 | 346 | 342 | 339 | 338 | 339 | 337 | 333 |
| Cash flow | ||||||||||
| Cash from operations | 3.2 | 2.9 | 3.0 | 2.7 | 3.7 | 2.7 | 2.7 | 3.5 | 3.2 | 2.8 |
| Capital expenditure | 0.8 | 0.8 | 0.9 | 1.2 | 1.2 | 1.0 | 0.9 | 0.8 | 0.7 | 1.1 |
| Free cash flow | 2.5 | 2.1 | 2.1 | 1.5 | 2.5 | 1.7 | 1.9 | 2.8 | 2.5 | 1.6 |
| Dividends paid | 1.3 | 1.4 | 1.4 | 1.4 | 1.5 | 1.5 | 1.6 | 1.6 | 1.6 | 1.7 |
| Share buybacks | 0.7 | 0.9 | 0.8 | 0.8 | 0.7 | 0.4 | 0.1 | 0.2 | 1.0 | 0.1 |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 1.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Stock-based compensation | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.0 | 0.1 | 0.2 | 0.1 | 0.1 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 0.9 | 0.6 | 0.5 | 0.4 | 0.3 | 0.3 | 0.4 | 1.1 | 1.0 | 0.7 |
| Debt incl. finance leases | 7.6 | 7.4 | 7.5 | 7.7 | 8.4 | 8.6 | 8.4 | 8.0 | 7.4 | 7.2 |
| Total assets | 14.6 | 15.2 | 14.5 | 15.3 | 17.5 | 17.8 | 18.0 | 17.3 | 16.5 | 17.1 |
| Total liabilities | 14.5 | 14.3 | 14.6 | 15.1 | 16.7 | 17.1 | 17.3 | 16.3 | 15.6 | 15.5 |
| Shareholders' equity | −0.1 | 0.6 | −0.3 | −0.0 | 0.6 | 0.5 | 0.5 | 0.9 | 0.8 | 1.5 |
| Margins and ratios | ||||||||||
| Gross margin | 36.6% | 35.9% | 30.3% | 32.7% | 35.6% | 30.8% | 30.8% | 36.6% | 37.4% | 36.0% |
| Operating margin | 18.5% | 18.3% | 12.1% | 16.2% | 16.9% | 13.2% | 13.3% | 11.2% | 16.1% | 14.3% |
| Net margin | 11.8% | 12.4% | 7.6% | 11.7% | 12.3% | 9.3% | 9.6% | 10.3% | 15.1% | 12.3% |
| Free cash flow margin | 13.5% | 11.7% | 11.3% | 8.3% | 13.1% | 8.9% | 9.2% | 16.2% | 14.9% | 10.0% |
| Return on capital | 33.6% | 34.4% | 22.7% | 32.6% | 30.4% | 22.4% | 23.8% | 19.2% | 29.9% | 21.5% |
| Return on equity | — | — | — | — | — | — | — | — | 290.0% | 172.6% |
| Return on assets | 14.7% | 15.3% | 9.5% | 14.5% | 14.3% | 10.3% | 10.8% | 10.0% | 15.0% | 12.0% |
| Net debt to EBITDA | 1.6x | 1.7x | 2.2x | 1.9x | 2.0x | 2.5x | 2.3x | 2.6x | 1.8x | 2.0x |